LIRAGLUTIDE
NDC 81607-018, LIRAGLUTIDE, injection, solution, from Orbicular Pharmaceutical Technologies Private Limited.
- Product NDC
- 81607-018
- Status
- Listed
- Labeler
- Orbicular Pharmaceutical Technologies Private Limited
- Dosage form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA217590
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/81607-018 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LIRAGLUTIDE6 mg/mL
Pharmacologic classes
GLP-1 Receptor Agonist [EPC]; Glucagon-Like Peptide 1 [CS]; Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 81607-018-01 | 81607001801 | 3 SYRINGE, PLASTIC in 1 CARTON (81607-018-01) / 3 mL in 1 SYRINGE, PLASTIC |
| 81607-018-02 | 81607001802 | 2 SYRINGE, PLASTIC in 1 CARTON (81607-018-02) / 3 mL in 1 SYRINGE, PLASTIC |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/bb66a46c-9019-4a98-8e5d-581109facfba
Use it
Look up 81607-018 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/81607-018 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 81607-018. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.